Characterisation of Modular Polyketide Synthases Designed to Make Pentaene Analogues of Amphotericin B

Yuhao Song,Mark Hogan,Jimmy Muldoon,Paul Evans,Patrick Caffrey
DOI: https://doi.org/10.3390/molecules29061396
IF: 4.6
2024-03-22
Molecules
Abstract:Glycosylated polyene macrolides are important antifungal agents that are produced by many actinomycete species. Development of new polyenes may deliver improved antibiotics. Here, Streptomyces nodosus was genetically re-programmed to synthesise pentaene analogues of the heptaene amphotericin B. These pentaenes are of interest as surrogate substrates for enzymes catalysing unusual, late-stage biosynthetic modifications. The previous deletion of amphotericin polyketide synthase modules 5 and 6 generated S. nodosus M57, which produces an inactive pentaene. Here, the chain-terminating thioesterase was fused to module 16 to generate strain M57-16TE, in which cycles 5, 6, 17 and 18 are eliminated from the biosynthetic pathway. Another variant of M57 was obtained by replacing modules 15, 16 and 17 with a single 15–17 hybrid module. This gave strain M57-1517, in which cycles 5, 6, 15 and 16 are deleted. M57-16TE and M57-1517 gave reduced pentaene yields. Only M57-1517 delivered its predicted full-length pentaene macrolactone in low amounts. For both mutants, the major pentaenes were intermediates released from modules 10, 11 and 12. Longer pentaene chains were unstable. The novel pentaenes were not glycosylated and were not active against Candida albicans. However, random mutagenesis and screening may yet deliver new antifungal producers from the M57-16TE and M57-1517 strains.
chemistry, multidisciplinary,biochemistry & molecular biology
What problem does this paper attempt to address?
This paper attempts to engineer *Streptomyces nodosus* to produce pentene analogs of Amphotericin B through genetic engineering. Specifically, the researchers aim to construct mutant strains of *Streptomyces* capable of synthesizing novel pentene compounds by deleting or replacing specific modules in modular polyketide synthases (PKSs). These pentene analogs, as potential antifungal drug precursors, may possess improved pharmacological properties such as reduced toxicity, increased water solubility, and enhanced bioactivity. The main objectives of the paper include: 1. **Constructing mutant strains of *Streptomyces* capable of producing pentene analogs**: By deleting or replacing specific modules in modular polyketide synthases, the length of the polyketide chain is reduced, resulting in the generation of new pentene analogs. 2. **Evaluating the stability and bioactivity of the new compounds**: Analyzing the chemical stability of these newly synthesized pentene analogs and their antifungal activity against *Candida albicans*. 3. **Exploring the potential for combinatorial biosynthesis**: Assessing whether these mutant strains can serve as hosts for further combinatorial biosynthesis studies to develop new antifungal drugs. Specifically, the researchers constructed two main mutant strains: - **M57-16TE**: Fusing a chain-terminating thioesterase (TE) to the 16th module, thereby eliminating the 17th and 18th extension cycles. - **M57-1517**: Replacing the 15th, 16th, and 17th modules with a 15/17 hybrid module, thereby reducing the length of the polyketide chain. Through these modifications, the researchers hope to obtain novel pentene compounds structurally similar to selvamicin (a uniquely modified pentene compound) and evaluate their feasibility as potential antifungal drugs.